β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: A meta-analysis

Molecular Biology Reports

Volumn 40, Issue 6, 2013, Pages 4055-4063

  Wang, Hao ^a   Liu, Jielin ^a   Liu, Kuo ^b   Liu, Ya ^a   Wang, Zuoguang ^a   Lou, Yuqing ^c   Niu, Qiuli ^a   Gu, Wei ^a   Wang, Lijuan ^a   Li, Mei ^a   Zhu, Xiaoling ^a   Wen, Shaojun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINA MEITAN GENERAL HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Adrenoceptor; Essential hypertension; Meta analysis; Polymorphism

Indexed keywords

ARGININE; BETA 1 ADRENERGIC RECEPTOR; GLYCINE;

ADRB1 GENE; ALLELE; ARTICLE; ASIAN; CASE CONTROL STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; ETHNICITY; GENETIC ASSOCIATION; HUMAN; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RECEPTORS, ADRENERGIC, BETA-1; RISK FACTORS; SAMPLE SIZE;

EID: 84877759925     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2483-1     Document Type: Article

References (48)

1. Chockalingam A, Campbell NR, Fodor JG (2006) Worldwide epidemic of hypertension. Can J Cardiol 22:553-555
2. Gu D, Gupta A, Muntner P et al (2005) Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation 112:658-665
3. Lander ES, Schork NJ (1994) Genetic dissection of complex traits. Science 265:2037-2048
4. Kurtz TW, Spence MA (1993) Genetics of essential hypertension. Am J Med 94:77-84
5. Bengtsson K, Melander O, Orho-Melander M et al (2001) Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation 104:187-190
6. Peng Y, Xue H, Luo L et al (2009) Polymorphisms of the beta1-adrenergic receptor gene are associated with essential hypertension in Chinese. Clin Chem Lab Med 47:1227-1231
7. Nieminen T, Lehtimäki T, Laiho J et al (2006) Effects of polymorphisms in beta1-adrenoceptor and alpha-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study. J Appl Physiol 100:507-511
8. Hu R, Zhao S, Niu G et al (2006) Association between essential hypertension and polymorphisms of beta 1 adrenergic receptor gene G1165C (Gly389Arg) in Chinese Mongolian population. Neural Regen Res 1:226-229
9. Filigheddu F, Reid JE, Troffa C et al (2004) Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade. Pharmacogenomics J 4:154-160
10. Ramu P, Rajan S, Shewade DG et al (2009) Genetic variants of beta(1)-adrenoceptor gene polymorphisms (Ser49Gly and Arg389Gly) and essential hypertension in a south Indian Tamil population. Clin Exp Pharmacol Physiol 36:576-582
11. Gjesing AP, Andersen G, Albrechtsen A et al (2007) Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects. Diabet Med 24:392-397
12. Börgel J, Schulz T, Bartels NK et al (2006) Modifying effects of the R389G beta1-adrenoceptor polymorphism on resting heart rate and blood pressure in patients with obstructive sleep apnoea. Clin Sci (Lond) 110:117-123
13. Whitworth JA (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983-1992
14. Mansia G, De Backer G, Dominiczak A et al (2007) 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 16:135-232
15. Ogihara T, Kikuchi K, Matsuoka H et al (2009) The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 32:3-107
16. Xie HG, Dishy V, Sofowora G et al (2001) beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 11:191-197
17. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253
18. Lau J, loannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820-826
19. Petitti DB (1994) Meta-analysis, decision analysis, and cost-effectiveness analysis. Oxford University Press, New York
20. Khan F, Pandey AK, Tripathi M et al (2007) Genetic affinities between endogamous and inbreeding populations of Uttar Pradesh. BMC Genet 8:12
21. Palanichamy MG, Sun C, Agrawal S et al (2004) Phylogeny of mitochondrial DNA macrohaplogroup N in India based on complete sequencing: implications for the peopling of South Asia. Am J Hum Genet 75:966-978
22. Quintana-Murci L, Chaix R, Wells RS et al (2004) Where west meets east: the complex mtDNA landscape of the southwest and Central Asian corridor. Am J Hum Genet 74:827-845
23. Yan L, Zhang D, Chen C et al (2009) TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis. Int J Cancer 125:2903-2911
24. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
25. Bengtsson Boström K, Hedner J, Grote L et al (2010) Polymorphisms in α- and β-adrenergic receptor genes, hypertension, and obstructive sleep apnea: the Skaraborg sleep study. Int J Hypertens. doi: 10.4061/2010/458410.
26. Shioji K, Kokubo Y, Mannami T et al (2004) Association between hypertension and the alpha-adducin, beta1-adrenoreceptor, and G-protein beta3 subunit genes in the Japanese population; the Suita study. Hypertens Res 27:31-37
27. Tikhonoff V, Hasenkamp S, Kuznetsova T et al (2008) Blood pressure and metabolic phenotypes in relation to the ADRB1 Arg389Gly and ADRA2B I/D polymorphisms in a White population. J Hum Hypertens 22:864-867
28. Zee RY, Bennett CL, Schrader AP et al (1994) Frequencies of variants of candidate genes in different age groups of hypertensives. Clin Exp Pharmacol Physiol 21:925-930
29. Ranade K, Jorgenson E, Sheu WH et al (2002) A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 70:935-942
30. Wilk JB, Myers RH, Pankow JS et al (2006) Adrenergic receptor polymorphisms associated with resting heart rate: the HyperGEN Study. Ann Hum Genet 70:566-573
31. Hassan M, York KM, Li H et al (2001) Association of beta1-adrenergic receptor genetic polymorphism with mental stress-induced myocardial ischemia in patients with coronary artery disease. Arch Intern Med 168:763-770
32. Small KM, McGraw DW, Liggett SB (2003) Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 43:381-411
33. Maqbool A, Hall AS, Ball SG et al (1999) Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay. Lancet 353:897
34. Palczewski K, Kumasaka T, Hori T et al (2000) Crystal structure of rhodopsin: a G protein- coupled receptor. Science 289:739-745
35. Mason DA, Moore JD, Green SA et al (1999) A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274:12670-12674
36. Rathz DA, Gregory KN, Fang Y et al (2003) Hierarchy of polymorphic variation and desensitization permutations relative to beta 1- and beta 2-adrenergic receptor signaling. J Biol Chem 278:10784-10789
37. Joseph SS, Lynham JA, Grace AA et al (2004) Markedly reduced effects of (-)-isoprenaline but not of (-)-CGP12177 and unchanged affinity of beta-blockers at Gly389-beta1-adrenoceptors compared to Arg389-beta1- adrenoceptors. Br J Pharmacol 42:51-56
38. Sandilands AJ, O'Shaughnessy KM, Brown MJ (2003) Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 138:386-392
39. Bruck H, Leineweber K, Temme T et al (2005) The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity. J Am Coll Cardiol 46:2111-2115
40. Kitsios GD, Zintzaras E (2010) Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: the CUMAGAS-HYPERT database. Am J Hypertens 23:305-313
41. Jorgenson E, Tang H, Gadde M et al (2005) Ethnicity and human genetic linkage maps. Am J Hum Genet 76:276-290
42. Storry JR (2003) Human blood groups: inheritance and importance in transfusion medicine. J Infus Nurs 26:367-372
43. Calafell F, Shuster A, Speed WC et al (1998) Short tandem repeat polymorphism evolution in humans. Eur J Hum Genet 6:38-49
44. Kramer H, Han C, Post W et al (2004) Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens 17:963-970
45. National Board of Health and Welfare, Drug Information Committee (1987) Treatment of mild hypertension, vol 1. National Board of Health and Welfare, Drug Information Committee, Stockholm
46. Medical Products Agency (1993) Treatment of hypertension in the elderly. Medical Products Agency, Stockholm
47. Bengtsson K, Orho-Melander M, Lindblad U et al (1999) Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and diabetes project. J Hypertens 17:1569-1575
48. Bøg-Hansen E, Lindblad U, Bengtsson K et al (1998) Risk factor clustering in patients with hypertension and non-insulin-dependent diabetes mellitus. The Skaraborg Hypertension Project. J Intern Med 243:223-232